ロード中...
Synergistic effect of antimetabolic and chemotherapy drugs in triple-negative breast cancer
The triple-negative breast cancer (TNBC) subtype comprises approximately 15% of all breast cancers and is associated with poor long-term outcomes. Classical chemotherapy remains the standard of treatment, with toxicity and resistance being major limitations. TNBC is a high metabolic group, and antim...
保存先:
| 主要な著者: | , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2022-05-01
|
| シリーズ: | Biomedicine & Pharmacotherapy |
| 主題: | |
| オンライン･アクセス: | http://www.sciencedirect.com/science/article/pii/S0753332222002323 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|